New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
University of Minnesota created on-site testing facility for COVID-19
On Apr. 3, 2020, the University of Minnesota announced it had created the stateï¾’s fourth on-site testing facility…
University of Nebraska developed a COVID-19 screening mobile app
On Apr. 3, 2020, UNMC aunched a groundbreaking mobile app for Apple Iphone to screen large groups of…
BD, BioGX announced FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.
On Apr. 3, 2020, BD (Becton, Dickinson) and BioGX announced that the U.S. Food and Drug Administration (FDA)…
Clinical trial for severely ill COVID-19 patients begun at Montefiore-Einstein
On Apr. 3, 2020, Montefiore Health System and Albert Einstein College of Medicine started treating very sick COVID-19…
OHSU launched in-house COVID-19 testing lab
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that it had established an in-house COVID-19…
Mary and Ryan Finley donated $3 million to Legacy Health, OHSU to combat COVID-19
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…
Penn Medicine launched trial to evaluate hydroxychloroquine to treat, prevent COVID-19
On Apr. 3, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…
XBiotech and BioBridge Global collaborate on FDA program to develop potential COVID-19 antibody-based treatment
On Apr. 3, 2020, XBiotech and BioBridge Global announced a collaboration to participate in a FDA investigational program…
Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients and establish international compassionate use program
On Apr. 2, 2020, Novartis announced plans to initiate a phase III clinical trial in collaboration with Incyte…
Map revealed hidden U.S. hotspots of Coronavirus infection at the country level
On Apr. 2, 2020, a University of Chicago team announced that it had mapped confirmed COVID-19 infections per…
University Hospital Basel, Switzerland transfused first two COVID-19 patients with INTERCEPT treated Coronavirus convalescent plasma
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
Cerus announced inclusion of pathogen reduction technology in ISBT recommendations for preparation of COVID-19 convalescent plasma
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
Amgen and Adaptive Biotechnologies to develop a therapeutic to prevent or treat COVID-19
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
FDA approved Emergency IND Use of Humanigen’s lenzilumab for compassionate use in COVID-19 patients
On Apr. 2, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the U.S….
Vanda Pharma announced initiation of FDA approved clinical study of Tradipitant patients with severe COVID-19 pneumonia
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
BioAegis accelerated multiple clinical trial submissions for severe COVID-19 pneumonia patients
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
Collaborative effort brings new COVID-19 treatment approach to Western New York
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
GW Hospital used VR technology to see into COVID-19 patientï¾’s lungs
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
UW-Madison, FluGen and Bharat Biotech announced development of CoroFlu, a coronavirus vaccine
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsin-Madison and the vaccine companies…
Philips enabled hospitals and GPs to remotely screen and monitor patients with COVID-19
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
ImmunityBio combined supercomputing power with Microsoft Azure to target infection -Doorway of the Coronavirus
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…